[Retracted] Synergistic Effect of Stereotactic Radiotherapy Combined with Karelizumab on Patients with Advanced NSCLC

Table 4

Comparison of KPS parameters of two groups ( ± s).

Groups	KFS		t	value
	Before treatment	After treatment
Control group (n = 54)	61.28 ± 9.41	71.46 ± 10.59	5.280	＜0.001
Observation group (n = 46)	60.29 ± 8.46	77.58 ± 10.46	8.716	＜0.001
t	0.549	2.896
value	0.548	0.005